계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Boundless Bio
company
About
Boundless Bio is a precision oncology company developing therapeutics directed against extrachromosomal DNA (ecDNA) in aggressive cancers.
- 51 - 100
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $46.40M
- Industries
- Biotechnology,Health Care,Life Science,Therapeutics
- Founded date
- Jan 1, 2018
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Boundless Bio is a company that develops novel cancer therapeutics intended to understand and treat intraceable cancers. It aims to be the foremost biopharma company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable cancers.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$151.40M
Boundless Bio has raised a total of
$151.40M
in funding over 2 rounds. Their latest funding was raised on
Apr 28, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 28, 2021 | Series B | $105M | 1 | — | — | Detail |
| Sep 19, 2019 | Series A | $46.40M | 1 |
ARCH Venture Partners
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
3
0
Boundless Bio has made 3 investments. Their most recent investment was on
Jun 25, 2019, when Haus raised 0.
Investors
Number of Lead Investors
Number of Investors
1
1
Boundless Bio is funded by 1 investors.
ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
ARCH Venture Partners
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
